Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 03 Mar 2022

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study

in Hematologic Malignancies

Alessandra Iurlo
Daniele Cattaneo
Silvia Artuso
Dario Consonni
Elisabetta Abruzzese
Gianni Binotto
Monica Bocchia
Massimiliano Bonifacio
Fausto Castagnetti
Sara Galimberti

Frontiers in Oncology

doi 10.3389/fonc.2022.839915

7,015 views
17 citations

Original Research

Published on 01 Mar 2022

Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India

in Hematologic Malignancies

Prashant R. Tembhare
Gaurav Chatterjee
Anumeha Chaturvedi
Niharika Dasgupta
Twinkle Khanka
Shefali Verma
Sitaram G. Ghogale
Nilesh Deshpande
Karishma Girase
Manju Sengar

Frontiers in Oncology

doi 10.3389/fonc.2022.779230

19,295 views
18 citations

Original Research

Published on 28 Feb 2022

A Novel Risk Defining System for Pediatric T-Cell Acute Lymphoblastic Leukemia From CCCG-ALL-2015 Group

in Hematologic Malignancies

Xiaoming Liu
Yao Zou
Li Zhang
Ye Guo
Yumei Chen
Wenyu Yang
Xiaojuan Chen
Shuchun Wang
Yingchi Zhang
Min Ruan

Frontiers in Oncology

doi 10.3389/fonc.2022.841179

4,823 views
12 citations

Original Research

Published on 28 Feb 2022

Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study

in Hematologic Malignancies

Willem Daneels
Michael Rosskamp
Gilles Macq
Estabraq Ismael Saadoon
Anke De Geyndt
Fritz Offner
Hélène A. Poirel

Frontiers in Oncology

doi 10.3389/fonc.2022.824704

8,306 views
15 citations

Original Research

Published on 28 Feb 2022

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma

in Hematologic Malignancies

Yujun Wei
Jinying Wang
Fei Chen
Xin Li
Jiajia Zhang
Man Shen
Ran Tang
Zhongxia Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.808290

3,883 views
13 citations

Original Research

Published on 28 Feb 2022

DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation

in Hematologic Malignancies

Majd Jawad
Michelle Afkhami
Yi Ding
Xiaohui Zhang
Peng Li
Kim Young
Mina Luqing Xu
Wei Cui
Yiqing Zhao
Stephanie Halene

Frontiers in Oncology

doi 10.3389/fonc.2022.849376

11,236 views
33 citations

Original Research

Published on 25 Feb 2022

Late Mortality, Subsequent Malignant Neoplasms and Hospitalisations in Long-Term Survivors of Adolescent and Young Adult Hematological Cancers

in Hematologic Malignancies

Annalisa Trama
Claudia Vener
Paolo Lasalvia
Alice Bernasconi
the Ada Working Group
Manuel Zorzi
Anita Andreano
Paolo Contiero
Gianfranco Manneschi
Fabio Falcini

Frontiers in Oncology

doi 10.3389/fonc.2022.823115

3,951 views
4 citations

Original Research

Published on 25 Feb 2022

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells

in Hematologic Malignancies

Wen Jiang
Fanglin Li
Yang Jiang
Shengli Li
Xiaoli Liu
Yaqi Xu
Binggen Li
Xiaoli Feng
Chengyun Zheng

Frontiers in Oncology

doi 10.3389/fonc.2022.739976

7,553 views
38 citations

Original Research

Published on 25 Feb 2022

A Prospective Phase II Study of Pegaspargase-COEP Plus Radiotherapy in Patients With Newly Diagnosed Extra-Nodal NK/T-Cell Lymphoma

in Hematologic Malignancies

Shaoxuan Hu
Ningjing Lin
Jiaxin Liu
Yan Sun
Weiping Liu
Xiaopei Wang
Yan Xie
Yuqin Song
Yi Wen
Jun Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.839252

2,948 views
4 citations

Editorial

Published on 25 Feb 2022

Editorial: Rising Stars in Hematologic Malignancies 2021

in Hematologic Malignancies

Liren Qian
Marcos De Lima
Alice S. Mims
Narendranath Epperla

Frontiers in Oncology

doi 10.3389/fonc.2022.858564

2,271 views

Case Report

Published on 24 Feb 2022

Case Report: Metagenomic Next-Generation Sequencing Can Contribute to the Diagnosis and Treatment of Disseminated Visceral Kaposi Sarcoma Following Allogeneic Haematopoietic Stem Cell Transplantation

in Hematologic Malignancies

Kuangguo Zhou
Jinhuan Xu
Zhen Shang
Hanying Sun
Kefeng Shen
Yi Xiao

Frontiers in Oncology

doi 10.3389/fonc.2022.848976

4,165 views
6 citations

Original Research

Published on 24 Feb 2022

Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing

in Hematologic Malignancies

Hua Yin
Mei Hong
Jun Deng
Lan Yao
Chenjing Qian
Yao Teng
Tingting Li
Qiuling Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.811151

5,758 views
5 citations

Editorial

Published on 24 Feb 2022

Editorial: Strengths and Challenges of Allo-SCT in the Modern Era

in Hematologic Malignancies

Michele Malagola
Raffaella Greco
Jacopo Peccatori
Alessandro Isidori
Rizwan Romee
Mohamad Mohty
Fabio Ciceri
Domenico Russo

Frontiers in Oncology

doi 10.3389/fonc.2022.850403

2,761 views
4 citations

Review

Published on 23 Feb 2022

Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?

in Hematologic Malignancies

Guldane Cengiz Seval
Meral Beksac

Frontiers in Oncology

doi 10.3389/fonc.2022.800711

6,836 views
6 citations

Original Research

Published on 23 Feb 2022

Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China

in Hematologic Malignancies

Xuefei Sun
Yuchen Wu
Ruixian Xing
Xueyan Bai
Jun Qian
Hong Zhu
Qu Cui
Yuedan Chen
Qing Liu
Wenyuan Lai

Frontiers in Oncology

doi 10.3389/fonc.2022.792274

3,964 views
6 citations

Original Research

Published on 22 Feb 2022

Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia

in Hematologic Malignancies

Xue Yi
Nitin Jain
LaKesla R. Iles
Mary L. Ayres
William G. Wierda
Varsha Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2022.833714

5,286 views
7 citations

Review

Published on 21 Feb 2022

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges

in Hematologic Malignancies

Francesca Perutelli
Rebecca Jones
Valentina Griggio
Candida Vitale
Marta Coscia

Frontiers in Oncology

doi 10.3389/fonc.2022.837531

10,490 views
22 citations

Systematic Review

Published on 18 Feb 2022

Clinical Significance of Circulating Cell-Free DNA Detection in Multiple Myeloma: A Meta-Analysis

in Hematologic Malignancies

Xueshi Ye
Wanli Li
Lifei Zhang
Junyao Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.852573

5,468 views
9 citations

Brief Research Report

Published on 18 Feb 2022

Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis

in Hematologic Malignancies

Hira Mian
Christine Eisfeld
Christopher P. Venner
Esther Masih-Khan
Moustafa Kardjadj
Victor H. Jimenez-Zepeda
Cyrus Khandanpour
Georg Lenz
Arleigh McCurdy
Michael Sebag

Frontiers in Oncology

doi 10.3389/fonc.2022.826342

7,983 views
9 citations

Review

Published on 17 Feb 2022

Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML

in Hematologic Malignancies

Julia-Annabell Georgi
Sebastian Stasik
Martin Bornhäuser
Uwe Platzbecker
Christian Thiede

Frontiers in Oncology

doi 10.3389/fonc.2022.841608

5,927 views
13 citations

Original Research

Published on 17 Feb 2022

Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey

in Hematologic Malignancies

Maria Teresa Voso
Felicetto Ferrara
Sara Galimberti
Alessandro Rambaldi
Adriano Venditti

Frontiers in Oncology

doi 10.3389/fonc.2022.828072

7,293 views
7 citations

Mini Review

Published on 16 Feb 2022

Progress of Hematopoietic Stem Cell Transplantation and Radiotherapy in the Treatment of Extranodal NK/T Cell Lymphoma

in Hematologic Malignancies

Khodr Terro
Layal Sharrouf
Jean El Cheikh

Frontiers in Oncology

doi 10.3389/fonc.2022.832428

5,795 views
6 citations

Review

Published on 16 Feb 2022

Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases

in Hematologic Malignancies

Thierry Soussi
Panagiotis Baliakas

Frontiers in Oncology

doi 10.3389/fonc.2022.808886

5,329 views
17 citations

Review

Published on 15 Feb 2022

The Research Progress in Physiological and Pathological Functions of TRAF4

in Hematologic Malignancies

Xueqin Ruan
Rong Zhang
Ruijuan Li
Hongkai Zhu
Zhihua Wang
Canfei Wang
Zhao Cheng
Hongling Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.842072

5,978 views
23 citations

2,064 articles

articles

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study

Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India

A Novel Risk Defining System for Pediatric T-Cell Acute Lymphoblastic Leukemia From CCCG-ALL-2015 Group

Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma

DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation

Late Mortality, Subsequent Malignant Neoplasms and Hospitalisations in Long-Term Survivors of Adolescent and Young Adult Hematological Cancers

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells

A Prospective Phase II Study of Pegaspargase-COEP Plus Radiotherapy in Patients With Newly Diagnosed Extra-Nodal NK/T-Cell Lymphoma

Editorial: Rising Stars in Hematologic Malignancies 2021

Case Report: Metagenomic Next-Generation Sequencing Can Contribute to the Diagnosis and Treatment of Disseminated Visceral Kaposi Sarcoma Following Allogeneic Haematopoietic Stem Cell Transplantation

Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing

Editorial: Strengths and Challenges of Allo-SCT in the Modern Era

Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?

Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China

Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges

Clinical Significance of Circulating Cell-Free DNA Detection in Multiple Myeloma: A Meta-Analysis

Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis

Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML

Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey

Progress of Hematopoietic Stem Cell Transplantation and Radiotherapy in the Treatment of Extranodal NK/T Cell Lymphoma

Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases

The Research Progress in Physiological and Pathological Functions of TRAF4